LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)
$0 None (None%)
Analysed LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) News Sources
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
04-09-2026
yahoo.com
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08-09-2026
yahoo.com
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig
21-09-2026
marketbeat.com
Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says
23-09-2026
yahoo.com
Lakefront Receives Transparency Notification from Bank of America
08-10-2026
yahoo.com
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
14-10-2026
yahoo.com
Belgian startup revives Galapagos CAR-T research
15-10-2026
biopharmadive.com
Acquisition of Own Shares
20-10-2026
yahoo.com
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Looks Undervalued Despite A 40% Five Year Fall
21-10-2026
yahoo.com
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?
21-10-2026
yahoo.com
What is the current price of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The current price of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is $0.
LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) since the previous trading day is $None.
LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The most recent average sentiment score for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is 63 out of 100.
What is the most recent average sentiment for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The most recent sentiment for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is .
SEC-8K** Filing Available For LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.